knowledge -WSS

knowledge

author：comprehensive 2025-10-01 14:14:52 - browse：7

Is biotech back from its downturn? Can Nvidia solve biology? And is it wise to do a deal on a party bus?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Recording from the J.P. Morgan Healthcare Conference, we discuss how a spate of deals and some intermittent sunshine seem to have brightened the outlook for biotech at the outset of 2024. We also talk about the latest twist in the Sarepta Therapeutics saga, a ubiquitous dealmaker, and life on the party circuit.

For more on what we cover, here’s the news on Sarepta; here’s more on Nvidia; here’s the story on Centerview; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Alkermes shareholders re
Next article： Alabama IVF ruling threatens families facing fatal genetic disease

leisure time

WSS

Is mRNA technology the right fit for flu shots? Experts aren’t so sure

What to do when lifesaving products contribute to climate change

Alabama hospital puts IVF treatments on hold

Dario to buy mental health app maker Twill in cash and stock deal

Saudi VC loops Novo Nordisk, biotech VCs into longevity incubator

6 phony surgeries that take placebo to the extreme

explore

knowledge

leisure time

Supreme Court strikes down use of affirmative action

Alabama IVF ruling threatens families facing fatal genetic disease

Anesthesiologist group: stop taking Ozempic before surgery

He's a Nobel laureate. Critics say he was misleading on Covid

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Medicare inequities exacerbate Puerto Rico’s health disparities

Trump demands the U.S. pay no more for drugs than other countries … again

Pediatric cancer treatments threatened by a new FDA policy

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

CDC director unscathed in first congressional testimony

focus

Fetal surgery at risk from Dobbs and new abortion restrictions

Alabama hospital puts IVF treatments on hold

ReNAgade cuts staff seven months after raising $300 million

Readout Newsletter: Alnylam, Celldex, Roche, Zealand Pharma

Takeda, Janssen join wearable maker to measure scratching

Alabama frozen embryo ruling has major implications for IVF clinics

knowledge

leisure time

hotspot

knowledge